Gorenjak, M.; Gole, B.; Goričan, L.; Jezernik, G.; Prosenc Zmrzljak, U.; Pernat, C.; Skok, P.; Potočnik, U.
Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease. Pharmaceutics 2024, 16, 835.
https://doi.org/10.3390/pharmaceutics16060835
AMA Style
Gorenjak M, Gole B, Goričan L, Jezernik G, Prosenc Zmrzljak U, Pernat C, Skok P, Potočnik U.
Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease. Pharmaceutics. 2024; 16(6):835.
https://doi.org/10.3390/pharmaceutics16060835
Chicago/Turabian Style
Gorenjak, Mario, Boris Gole, Larisa Goričan, Gregor Jezernik, Uršula Prosenc Zmrzljak, Cvetka Pernat, Pavel Skok, and Uroš Potočnik.
2024. "Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease" Pharmaceutics 16, no. 6: 835.
https://doi.org/10.3390/pharmaceutics16060835
APA Style
Gorenjak, M., Gole, B., Goričan, L., Jezernik, G., Prosenc Zmrzljak, U., Pernat, C., Skok, P., & Potočnik, U.
(2024). Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease. Pharmaceutics, 16(6), 835.
https://doi.org/10.3390/pharmaceutics16060835
